Conscientia Beam || conscientiabeam.com

Export to

Citations

Contact Us

For Marketing, Sales and Subscriptions Inquiries

2637 E Atlantic Blvd #43110
Pompano Beach, FL 33062

USA

Conference List

Journal of Diagnostics

December 2016, Volume 3, 2, pp 31-37

Seroprevalence of Herpes Simplex Virus Type 2 (HSV-2) Infection Among HIV Patients Accessing Healthcare at Federal Medical Centre, Keffi, Nigeria

Pennap, G. R. I.

Oti, V. B.

Pennap, G. R. I.¹ ^,

Oti, V. B.¹

Department of Microbiology, Nasarawa State University Keffi, Nigeria ¹

on Google Scholar

on PubMed

Pages: 31-37

DOI: 10.18488/journal.98/2016.3.2/98.2.31.37

Article History:

Received: 20 April, 2016
Revised: 20 May, 2016
Accepted: 17 October, 2016
Published: 07 December, 2016

View Citation

1109Views

Create Citation Alert

Abstract:

Herpes simplex virus type 2 (HSV-2) infections is a sexually transmitted infection worldwide, which has a public health implications especially as a driving force behind the Human Immunodeficiency Virus (HIV) epidemic. It is known to cause genital ulcer as well as lesions. It is a lifelong recurrent disease with no cure. Due to the lack of documented HSV-2 studies among HIV patients in this study area with an estimated HIV prevalence of 38.7%, there was a need for estimating the seroprevalence of HSV-2 infection in the study population. The sera of 223 consenting HIV positive patients were screened for HSV-2 specific IgG using an ELISA test kit (Cortez Diagnostic, Inc, USA). The chi-square test was performed to identify possible risk factors associated with the viral seropositivity. The overall seroprevalence of the viral infection was 77.6%. Females recorded a prevalence of 84.5% and males 51.0% (p > 0.05). Participants aged ≤ 20 and ≥ 61 years recorded a prevalence of 100%, while the lowest prevalence (66.7%) was observed in those aged 51-60 years (p > 0.05). There was a statistically significant association between the seroprevalence of HSV-2 in HIV patients in relation to locality. Patients from the rural setting had a higher prevalence (85.2%) of the infection than those from the urban setting (72.6%) (p ≤ 0.05). However, in this study, marital status, occupation, level of education, antiretroviral therapy (ART) status and CD4 counts, had no statistically significant association with HSV-2 infection (p > 0.05). Awareness campaigns that will promote behavioral change might be the most important strategy to mitigate transmission as most of the infected persons usually show no clinical symptoms. The role of vaccination and condom use among high risk groups may help in combating the transmission.

Contribution/ Originality
This study has contributed in documenting the prevalence of the infection in Keffi using the ELISA test kit and has used the Chi square statistical test. This study is one of the very few studies which have investigated the prevalence of HSV-2 infection in North central, Nigeria. The paper has contributed in logical analysis and in estimating the prevalence and risk factors of the infection in Keffi. The study documented a very high overall prevalence of the infection. It is associated with gender, age and locality and not associated with marital status, occupation, level of education, ART and CD4 counts.

Keywords:

HSV-2, HIV, ELISA, Seroprevalence, Keffi

Video:

Download Video

Download Audio

Reference:

F. Xu, M. R. Stemberg, S. L. Gottlieb, S. M. Bermen, and L. E. Markowitz, "Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years------- United States, 2005-2008," Morbidity and Mortality Weekly, vol. 59, pp. 456-459, 2010.
E. I. Kalu, K. Akubuo, F. E. Agwu, E. O. Yusuf, C. K. Ojide, and V. U. Nwadike, "Seroprevalence of herpes virus-2 among antenatal clinic attendees in Benin, Nigeria," International Journal of Tropical Disease and Health, vol. 4, pp. 330-334, 2014.
Y. A. Agabi, E. B. Banwat, J. D. Mawak, P. M. Lar, N. Dashe, M. M. Dashen, M. P. Adoga, F. Y. Agabi, and H. Zakari, "Seroprevalence of herpes simplex virus type 2 among patients attending the sexually transmitted infections clinic in Jos, Nigeria," Journal of Infectious Diseases, vol. 4, pp. 527-575, 2010.
R. Varo, W. C. Buck, P. N. Kazembe, S. Phiri, D. Adriarinamana, and R. Weigel, "Seroprevalence of HIV, HSV-2 and HBV among HIV infected Malawian children: A cross-sectional survey," Journal Tropical Pediatrics, vol. 63, pp. 220-226, 2016.
N. Soumyabrata, S. Soma, C. Debprasad, S. Bhattacharrya, B. Rahul, and S. Manideepa, "Seroprevalence of herpes simplex virus infection in HIV coinfected individuals in Eastern India with risk factor analysis," Advances in Virology, vol. 1, pp. 7-10, 2015.
N. Sherwani, R. Khadse, and D. Bhawani, "A study on herpes simplex virus type-2 specific seroprevalence among HIV positive patients of a tertiary care hospital in central India," Research Paper, vol. 5, pp. 37-41, 2015.
O. Lupi, "Prevalence and risk factors for herpes simplex infection among patients at high risk for HIV infection in Brazil," International Journal of Dermatology, vol. 50, pp. 709-713, 2011.
J. A. Cohen, A. Sellers, T. S. Sunil, P. E. Mattews, and J. F. Okulicz, "Herpes simplex virus seroprevalence and seroconversion among active duty US air force members with HIV infection," Journal of Clinical Virology, vol. 74, pp. 4-7, 2016.
A. Munawwar and S. Singh, "Human herpes virus as copathogens of HIV infection, their role in HIV transmission, and disease progression," Journal of Laboratory Physicians, vol. 8, pp. 5-16, 2016.
V. L. Akwa, N. L. Bimbol, K. L. Samaila, and N. D. Markus, Geographical perspective of Nasarawa state. Keffi: Onaivi Printing and Publishing Company, 2007.
R. M. Coleman, L. Perirera, D. Bailey, C. Dondero, and N. A. J. Wickliffe, "Determination of herpes simplex virus-specific antibodies by enzyme-linked immunosorbent assay," Journal of Clinical Microbiology, vol. 18, pp. 287-291, 1983.
J. D. Mawak, N. Dashe, A. B. Nyese, Agabi, and H. Zakari, "Seroprevalence and coinfection of herpes simplex virus type 2 and human immunodeficiency virus in Nigeria," Journal of Infectious Diseases, vol. 26, pp. 1152-2311, 2012.
A. A. Oni, F. D. Adu, and C. C. Ekweozor, "Isolation of herpes simplex virus from sexually transmitted disease patients in Ibadan, Nigeria," Sexually Transmitted Diseases, vol. 21, pp. 187-190, 1994.
B. Romanovski, "Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada," Sexually Transmitted Diseases, vol. 36, pp. 165-169, 2009.
J. Wang, D. Y. Hrvang, H. Yu, S. S. Kim, J. K. Lee, and M. Kee, "Hospital based HIV/HSV-2 seroprevalence among male patients with anal disease in Korea: Cross-sectional study," BMC Infectious Diseases, vol. 14, pp. 1-34, 2014.
K. E. Iche, "Seroprevalence of herpes simplex virus infection among pregnant women attending antenatal clinic in Benin Nigeria," International Journal of Tropical Disease and Health, vol. 4, pp. 70-81, 2014.
H. Weis, "Epidemiology of herpes simplex virus type 2 infection in the developing world," Herpes, vol. 11, pp. 24 - 35, 2004.
C. Isichei, P. Brown, M. Isichei, J. Njab, T. Oyebode, and P. Okonkwo, "HIV prevalence and associated risk factors among rural pregnant women in North central Nigeria," American Journal of Health Research, vol. 3, pp. 18-23, 2015.
V. P. Amudha, G. Sucilathangan, B. Cinthuja, and C. Revalthy, "Serologic profile of HSV-2 in STD patients: Evaluation of diagnostic utility of HSV-2 IgM and IgG detection," Journal of Clinical Diagnosis Research, vol. 8, pp. 16 -19, 2014.
C. M. Posavad, A. Wald, S. Kuntz, M. L. Huang, S. Selke, E. Krantz, and L. Corey, "Frequent reactivation of HSV-2 among HIV-1 infected patients treated with highly active retreoviral therapy," Journal of Infectious Diseases, vol. 190, pp. 693 - 696, 2004.